CVXL-0103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCVXL-0103
Drug Alias NameCVXL-0103
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCaspase-9 inhibitors
TargetsCaspase-9
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClevexel Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClevexel Pharma
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A